Vermillion has appointed director Bruce Huebner as its interim CEO. Huebner succeeds former CEO Gail Page, who will be strategic advisor to the company and continue to serve on the board of directors.
Previously, Vermillion's board formed a committee of independent directors and charged them with selecting a new CEO for the firm. Vermillion has also engaged an executive search agency to look potential candidates.
Huebner has been a part of executive management teams at other clinical diagnostic companies, including Osmetech Molecular Diagnostics, Nanogen, and Gen-Probe. He was president of Osmetech, as well as president and COO of Nanogen.
CombiMatrix Corporation announced that Jeremy Jones, a veteran healthcare services executive, will join its board of directors. Jones fills a vacancy on the board that now brings the number of members to six.
Jones is chairman of On Assignment, Byram Healthcare Centers, and Lifecare Solutions and is a member of the advisory board of MedidaMetrics.
The New York Genome Center has appointed RNA genomics expert Robert Darnell as its president and scientific director.
Darnell will direct NYGC's scientific and research activities, as well as recruit and build scientific research teams at the center. Darnell is a member of NYGC's founding board and has joined the center's board of directors.
Additionally, Nancy Kelley, the founding executive director and member of the NYGC board of directors has been appointed the center's chief operating officer.